Improving treatment success rates for type 2 diabetes: recommendations for a changing environment.

The American journal of managed care

Volumn 16, Issue 7 Suppl, 2010, Pages

  Triplitt, Curtis ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1; GLYCOSYLATED HEMOGLOBIN;

ALGORITHM; DECISION SUPPORT SYSTEM; DISEASE COURSE; DRUG POTENTIATION; HEALTH INSURANCE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME;

ALGORITHMS; DECISION SUPPORT SYSTEMS, CLINICAL; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DISEASE PROGRESSION; GLUCAGON-LIKE PEPTIDE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MANAGED CARE PROGRAMS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 79952108563     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Review

References (0)